Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
62 (26%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-OXYCODONE CR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-12-18 | 2019-02-08 | 69921 |
| APO-OXYCODONE CR | 80.0MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-23 | 2023-08-12 | 196312 |
| APO-OXYCODONE CR | 15MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-10-27 | 2023-11-06 | 208382 |
| APO-OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE) | Resolved | 2023-05-26 | 2023-08-12 | 193224 |
| APO-OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-02 | 2023-08-12 | 193614 |
| APO-OXYCODONE CR | 20.0MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-10-11 | 2018-03-13 | 25304 |
| APO-OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-12-20 | 2018-03-21 | 33867 |
| APO-OXYCODONE/ACET | 5MG 325MG | TABLET | Resolved | 2020-06-10 | 2020-06-18 | 117401 |
| APO-OXYCODONE/ACET | 5MG 325MG | TABLET | Resolved | 2020-06-10 | 2020-06-18 | 117404 |
| APO-OXYCODONE/ACET | 5MG 325MG | TABLET | Resolved | 2020-07-08 | 2020-09-21 | 119762 |
| APO-OXYCODONE/ACET | 325MG 5MG | TABLET | Resolved | 2017-03-11 | 2017-04-07 | 426 |
| APO-OXYCODONE/ACET | 325MG 5MG | TABLET | Resolved | 2017-05-10 | 2017-07-04 | 9936 |
| APO-OXYCODONE/ACET | 325MG 5MG | TABLET | Resolved | 2022-03-25 | 2022-05-27 | 157323 |
| APO-OXYCODONE/ACET | 325MG 5MG | TABLET | Resolved | 2022-06-12 | 2022-07-23 | 162478 |
| APO-OXYCODONE/ACET | 5MG 325MG | TABLET | Resolved | 2020-10-14 | 2020-10-26 | 126303 |
| APO-OXYCODONE/ACET | 325MG 5MG | TABLET | Resolved | 2023-05-06 | 2023-08-04 | 191883 |
| APO-OXYCODONE/ACET | 325MG 5MG | TABLET | Resolved | 2017-07-26 | 2018-03-17 | 17266 |
| APO-PACLITAXEL INJECTABLE | 6MG | SOLUTION | Actual shortage | 2017-08-14 | 2017-10-05 | 19133 |
| APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2017-07-26 | 2017-08-28 | 17296 |
| APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-09-09 | 2022-09-30 | 169060 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |